For more than 30 years, CDC has worked to help strengthen the health system in Kenya, working in partnership with the government of Kenya and local and international partners to build sustainable public health capacity.

CDC Kenya saves lives through research and development of new interventions, such as vaccines, drugs, and diagnostics, and development of the leadership and scientific expertise required to build effective public health systems.


Kenya faces both a generalized and a concentrated HIV epidemic that continues to have a devastating impact on all sectors of society. The HIV epidemic in Kenya affects more females than males and data has also shown that HIV is spreading very rapidly in most-at-risk populations (MARPs) who now account for a third of all the new infections in the country (Kenya Modes of Transmission Study 2008) while heterosexual sex continues to be the main mode of transmission. The goal of this Program is to contribute to the reduction of new infections and AIDS-related morbidity and mortality for an HIV-free society. This Program is a stand-alone single stream of funding (SSF) Round 10 HIV grant and is implemented by two Principal Recipients (PR) under dual-track financing. The current PR will focus on scaling up the number of people under anti-retroviral therapy (ART) and also intends to target MARPs (men who have sex with men, sex workers and injecting drug users) with a component designed to improve the technical and programmatic capacity of implementers.



The United States (U.S.) is proud to support Kenya’s leadership in the global HIV/AIDS response. PEPFAR (The United States President’s Emergency Plans for AIDS Relief) provides service delivery and technical assistance in Kenya to maximize the quality, coverage, and impact of the national HIV/AIDS response. Working together with the Government of Kenya, PEPFAR is aligning investments to scale up interventions that are most effective in the areas and populations with the highest burden of HIV/AIDS – in line with PEPFAR 3.0